Eli Lilly anunci que su frmaco experimental retatrutida logr una prdida de peso promedio del 28% en 80 semanas , superando ampliamente a los tratamientos actualmente disponibles y acercndose a los resultados de la ciruga baritrica
Body composition analyses reveal Retatrutide produces greater fat mass reduction relative to total weight loss
Common use of these medications is likely to decrease complications of metabolic disease, which will lead to some cost savings, although will probably not lower total medical expenses unless the cost of the GLP-1s goes down further
Whether you choose oral supplements, medical injections, or simply eating more nutrient-dense foods, always prioritize safety and consult with your doctor before making changes to your health regimen.
NAD for injection is a compounded product, not FDA approved for energy or aging, and is used under provider supervision